This brand name is authorized in Estonia, Lithuania, Netherlands, Poland, Singapore, South Africa, Spain.
The drug WARTEC contains one active pharmaceutical ingredient (API):
1
|
UNII
L36H50F353 - PODOFILOX
|
|
Podophyllotoxin is a metaphase inhibitor in dividing cells binding to at least one binding site on tubulin. Binding prevents tubulin polymerisation required for microtubule assembly. At higher concentrations, podophyllotoxin also inhibits nucleoside transport through the cell membrane. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D06BB04 | Podophyllotoxin | D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1033681, 1094026 |
| ES | Centro de información online de medicamentos de la AEMPS | 58844, 61338 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1019431 |
| NL | Z-Index G-Standaard | 14150212 |
| NL | Z-Index G-Standaard, PRK | 48356 |
| PL | Rejestru Produktów Leczniczych | 100099136 |
| SG | Health Sciences Authority | 11584P, 11585P |
| ZA | Health Products Regulatory Authority | 28/13.9/0142 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.